tirzepatide semaglutide peptide or small molecule Structural insights into multiplexed pharmacological actions of and 20 at the GIP, GLP-1 glucagon receptors Tirzepatide Tops Semaglutide for Weight

We believe that sustainable weight loss is achieved through science, empathy, and a transparent approach

Front Endocrinol (Lausanne) 14:1268619

Popular weight loss drugs such as Wegovy and Ozempic, are associated with an increased risk of stomach paralysis, pancreatitis and bowel obstruction, according to a study released Thursday out of the University of British Columbia

However, Mounjaro targets both GLP-1 and GIP receptors, making it a dual-action medication that may offer greater appetite suppression and improved metabolism for some patients

The glucagon component adds potential for modest heart rate increases (+35 bpm at higher doses) and transient blood glucose elevations in some patients

[DOI] [PubMed] [Google Scholar] 170.Nian M, Drucker DJ, Irwin D